Pharmacokinetics: Warfarin

Slides:



Advertisements
Similar presentations
Connecting Pharmacology with Therapeutics Clive Roberts.
Advertisements

Warfarin (Coumadin® / Jantoven®)
Clinic Patient Education
Minimizing risk and Optimizing Safety
Diabetes and Hypothyroidism
JOURNAL REVIEW Newer Antithrombotics in AF 1 Dr Ranjith MP Senior Resident Department of Cardiology Government Medical college Kozhikode.
What a Bloody Mess! A/Professor Kent Robinson Senior Staff Specialist, Liverpool & Campbelltown Hospitals.
Warfarin toxicity Presented by: Dr.Somaia Janah Presented by: Dr.Somaia Janah.
Warfarin Sodium (Anticoagulant) Therapy Training 03/10/2015.
7. Anti-TB regimen in special situations of liver disease, renal impairment, and pregnancy.
Medication Reconciliation Concord Regional Visiting Nurse Association Spring 2012.
Chapter Eight Venous Disease Coalition Safe Use of Oral Anticoagulants VTE Toolkit.
Study by: Granger et al. NEJM, September 2011,Vol No. 11 Presented by: Amelia Crawford PA-S2 Apixaban versus Warfarin in Patients with Atrial Fibrillation.
Oral Anticoagulant Therapy Benedict R. Lucchesi, M.D., Ph.D. Department of Pharmacology University of Michigan Medical School.
Guidelines to Lower Risk of Drug-Nutrient Interactions
Margaret Jin, BScPHM, PharmD, CGP November Learning Objectives To review the mechanism of action, indications, contraindications, adverse reactions,
Mosby items and derived items © 2007 by Mosby, Inc., an affiliate of Elsevier Inc. Chapter 25 Drug Interactions.
Association of polymorphisms in the cytochrome P450 CYP2C9 with warfarin dose requirement and risk of bleeding complications Mark Bleackley MEDG 505 March.
Vanderbilt Pediatric Hematology Anticoagulation Guidance Protocol Robert F. Sidonio, Jr. MD, MSc. 4/12/12 Warfarin Monitoring If inpatient, consider monitoring.
DRUG INTERACTIONS IN EMERGENCY MEDICINE: AN OVERVIEW SCOTT LINSCOTT, MD UNIVERSITY OF UTAH SCHOOL OF MEDICINE.
Factors Affecting Drug Activity Chapter 11 Pages
Study Guide Guide for Patients Undergoing Anticoagulant Therapy.
Food-Drug Interactions Chapter 19. © 2004, 2002 Elsevier Inc. All rights reserved. Key Terms n Bioavailability: degree to which a drug or other substance.
Lecture 5b 3 Feb 2014 Atherosclerosis-Nutritional intervention- -emphasis should be on prevention-
Problems of Polypharmacy
Copyright © 2013, 2010 by Saunders, an imprint of Elsevier Inc. Chapter 8 Individual Variation in Drug Responses.
Alison Wong Meme Phung Zhi Yuan Quek. CASE Mr. AR, aged 55 years Recently been prescribed amiodarone as treatment for atrial tachyarrhythmia Medications.
By: Hadeel Al-Kofide MS.c
Management of Patients Taking Anticoagulants Darwin Deen, MD, MS.
Quantitative Pharmacokinetics
Agents Affecting Blood Clotting
Challenges to drug design Did you know? Over 2 million people are hospitalized each year for adverse reactions to prescription drugs. Over 2 million.
Case 4 Chang Chia-Chieh(Tony). Mr. Reyes was prescribed Lovastatin 20mg. b.i.d. and told to return in 6 weeks.
Foundation Knowledge and Skills
Pharmacokinetics: Digoxin Allie Punke
ALLIE PUNKE PHARMACOKINETICS: ANTIEPILEPTIC DRUGS.
Warfarin Therapy Aaqid Akram MBChB (2013) Clinical Education Fellow.
ALLIE PUNKE PHARMACOKINETICS: PSYCHOTROPIC DRUGS.
ALLIE PUNKE PHARMCOKINETICS. PHENYTOIN THE BASICS What is the volume of distribution: Regular floor patient: L/kg Critically ill patient: 0.8.
Communicating with Patients and Providers HIV Care and ART: A Course for Pharmacists.
ANTICOAGULATION The objectives of this section are: To be able to write prescriptions according to local anticoagulation guidelines To know how to prescribe.
The Complete Health History QUESTIONS ????????????????
Liver Disease tutoring Part 1
Minimizing risk and Optimizing Safety
Pharmacokinetics: psychotropic drugs
Allie punke pharmcokinetics Allie punke
Hypothyroidism management
Pharmacokinetics.
Pharmacokinetics.
Pharmacokinetics: Warfarin
Pharmacokinetics: HIV Drugs
Pharmacokinetics.
Anticonvulsants: Valproic acid
Understanding the Basics of Pharmacology
UCSDHS Anticoagulation Reversal Guidelines
Use of NOACs is contraindicated for AF patients with mechanical prosthetic valves or moderate- severe mitral stenosis (usually of rheumatic origin). Although.
Metronidazole By Rajesh Patel.
Anticoagulation Prepared by Cherie Gan.
Pharmacokinetics: Theophylline
Pharmacokinetics: immunosuppressive drugs
Factors affecting Drug Activity
Pharmcokinetics Allie punke.
Pharmcokinetics Allie punke.
Allie Punke Pharmacokinetics Allie Punke
Pharmcokinetics Allie punke.
Therapeutic Drug Monitoring
REFERENCE: APPLIED CLINICAL Slideshow by: lecturer HADEEL DELMAN
Thyroid Hormones (T4 & T3)
Chapter 11: Therapeutic Medications
POLYPHARMACY.
Presentation transcript:

Pharmacokinetics: Warfarin Allie Punke (apunke@uthsc.edu)

The Basics Most of the anticoagulant activity of warfarin is due to which isomer? S What clotting factors does warfarin inhibit? 7, 9, 10, 2 Protein C +S Which factor is reflected in the measurement of PT/INR? 7 Which factor is responsible for the antithrombotic effect? 2 and 10

The Basics When do we recommend loading doses of warfarin? And what is the dose? Healthy, young patients: 10 mg X 2 doses (2 days) How is the interaction with tube feedings avoided? Hold tube feedings 1 hour before and 1 hour after warfarin is given Which enzymes metabolize warfarin? R: 1A2, 2C19, 3A4 S: 2C9 and 3A4

True OR False A patient taking Cefdinir may experience a lowering of her INR due to the gut flora being altered. False (INR would be increased) The interaction of aspirin and warfarin is due to warfarin being displaced from protein binding sites causing an increased INR. False (It doesn’t displace binding sites) Low Extraction Drug: Css,u= D/Clint A chronic alcoholic can be expected to have consistently decreased INR. True Patients who smoke may require less warfarin, since they are more “sensitive” to it. False False True

Application Warfarin, a highly protein bound drug, is added on to a patient’s medication regimen along with a drug that displaces warfarin from albumin. How should we handle this? A. Because warfarin is a High E drug, the dose should be reduced to prevent excess free warfarin. B. Because warfarin is a Low E drug, the dose should be increased to ensure therapeutic INR. C. Because warfarin is a Low E drug, the dose should be reduced to prevent excess free warfarin. D. Because warfarin is a Low E drug, no change needs to be made.

Application A patient is being managed on warfarin for atrial fibrillation. Additionally, her physician wants to start her on amiodarone. The physician asks you how to manage the interaction. A. The interaction usually occurs after being on amiodarone for 3 months and the dose of warfarin does not depend on the dose of amiodarone. B. The interaction usually occurs after being on amiodarone for about 2 weeks and the dose of amiodarone can be used to guide the dosing of warfarin. C. The interaction time is variable, but the dose of amiodarone can be used to guide the dosing of warfarin. D. The interaction time is variable and the dose of warfarin does not depend on the dose of amiodarone. C. Peak effect is 1 week to 5 months. What is the interaction due to? CYP2C9, 1A2, 3A4.

Application The patient is started on 200 mg of amiodarone. How should the dose of warfarin be adjusted if she takes 5 mg of warfarin daily?

Application A patient needs to be started on a bile acid sequestrant. Which would be best to recommend to avoid a documented interaction with warfarin? Welchol How can we tell the patient to take cholestyramine or colestipol with warfarin? Take 1 hour before or 4-6 hours after

Application—To Load or Not to Load MB, 24 YO woman, was diagnosed with a DVT and needs to be initiated on warfarin. Should we give her a LD or not? Yes JP, 75 YO, needs to be started on warfarin. Actual Body Weight= 58 kg. PMH=history of liver disease. Home medications= lisinopril and hydrochlorthiazide, amiodarone. Should we give him a LD or not? No (elderly, liver disease, weight)

Application-Drug Interactions Match each drug with Increased or Decreased INR Garlic Increased Barbiturates Decrease Ginseng Procoagulant Metronidazole Increase St. John’s Wort Decreased Fluoroquinolones Increased Amiodarone Increased Rifampin Decreased Septra Increase Black cohosh Antiplatelet Carbamazepine Decreased Fab 5: Increase INR: - Flagyl, FQ, fluconazole, aminodarone, bactrim

Application-Drug Interactions How do we manage these drug interactions? Rifampin: Onset of interaction: 5-10 days Dosage change: Increase warfarin by 100-200% Offset of interaction: Decrease warfarin by 50% 1-2 weeks after rifampin is D/C Rifampin (5-10 day delay in interaction onset) and may require 100-200% increase. OFFSET is difficult to predict. Should decrease warfarin dose by 50% 1-2 weeks after rifampin is discontinued.

Application BA, a 85 year old patient, is taking warfarin correctly, but she has been taking double of her levothyroxine dose chronically for the past 1.5 months. How (if at all) does this affect INR? A. Her INR will be elevated due to the levothyroxine inhibiting the metabolism of warfarin B. Her INR will be decreased due to impaired metabolism of clotting factors C. Her INR will be elevated due to rapid metabolism of clotting factors D. Her INR will be decreased due to the excess levothyroxine stimulating metabolism of warfarin C

Summary Always check for drug interactions if a patient is taking warfarin. Know when a LD is appropriate. Know how certain disease states and medications can affect the dose of warfarin. Always counsel on the effects of Vitamin K foods and recommend to maintain a consistent diet of these.

Questions?